Walnut Level Capital’s Chemours CC Stock Holding History

Walnut Level Capital’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-110,000	Closed	-$2.48M	–	39
2024 Q2	$2.48M	Buy	+110,000	New	+$2.88M	1.1%	24

Other funds holding CC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

Walnut Level Capital's CC Position: Q1 2025 in Review

Walnut Level Capital sold out of Chemours (CC) in Q1 2025, closing a stake of 80,000 shares — an estimated $1.35M sold.

Walnut Level Capital first reported a position in CC in Q2 2024 and held it in 3 quarters. The position peaked at $1.35M in Q4 2024. 419 funds tracked by Wall St. Rank hold CC as of Q1 2025.

Walnut Level Capital reported no remaining Chemours position as of Q1 2025 after selling out during the quarter.
Walnut Level Capital sold 80,000 Chemours shares in Q1 2025, an estimated $1.35M.
Walnut Level Capital first reported a position in Chemours in Q2 2024 and held it in 3 quarters.
Walnut Level Capital's Chemours position peaked at $1.35M in Q4 2024.
419 funds tracked by Wall St. Rank held Chemours as of Q1 2025.

Based on Walnut Level Capital's 13F filing for Q1 2025, filed 15 May 2025.